ReleVote

Interagency Patent Coordination and Improvement Act of 2025

Bill Number
S. 1097
Origin Chamber
Senate
Congress
119th Congress, Session 1
Policy Area
Commerce
Status
Introduced
Latest Action
2025-04-10: Placed on Senate Legislative Calendar under General Orders. Calendar No. 41.
Last Updated
2025-12-05T21:51:50Z

Official Summary

Interagency Patent Coordination and Improvement Act of 2025

This bill establishes the Interagency Task Force on Patents to support coordination and communication between the U.S. Patent and Trademark Office (USPTO) and the Food and Drug Administration (FDA) on activities relating to patents for human drugs and biological products.

The task force's duties shall include sharing information about (1) the processes of each agency, including how each agency evaluates applications (e.g., patent applications at the USPTO and new drug applications at the FDA); and (2) new approvals of patents, human drugs, biological products, and new technologies. The task force must also establish a process that requires (1) the USPTO to request from the FDA information relating to certain patent applications to help patent examiners carry out their duties, (2) the FDA to provide such information to the USPTO, and (3) the USPTO to assist the FDA in its ministerial role of listing patents.

Sponsor

Sen. Durbin, Richard J. [D-IL]

Cosponsors (4)

Sen. Tillis, Thomas [R-NC], Sen. Grassley, Chuck [R-IA], Sen. Coons, Christopher A. [D-DE], Sen. Welch, Peter [D-VT]

Recent Actions

Bill Versions

Related Bills